Literatur
-
1
Ahlquist D A, Skoletsky J E, Boynton K A. et al .
Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.
Gastroenterology.
2000;
119
1219-1227
-
2
Arnold C N, Blum H E.
Molekulare Pathogenese des Kolonkarzinoms: Klinische Relevanz.
Dtsch Med Wochenschr.
2005;
130
809-811
-
3
Arnold C N, Goel A, Boland C R.
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
Int J Cancer.
2003;
106
66-73
-
4
Barratt P L, Seymour M T, Stenning S P. et al .
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study.
Lancet.
2002;
360
1381-1391
-
5
Calistri D, Rengucci C, Bocchini R, Saragoni L, Zloi W, Amadori D.
Fecal multiple molecular tests to detect colorectal cancer in stool.
Clin Gastro Hepatol.
2003;
1
377-383
-
6
Carethers J M, Smith E J, Behing C A. et al .
Use of 5-fluorouracil and survival in patients with microsatellite unstable colorectal cancer.
Gastroenterology.
2004;
126
394-401
-
7
Dong S M, Traverso G, Johnson C. et al .
Detecting colorectal cancer in stool with the use of multiple genetic targets.
J Natl Cancer Inst.
2001;
93
858-865
-
8
Fallik D, Borrini F, Boige V. et al .
Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
Cancer Res.
2003;
63
5738-5744
-
9
Müller H M, Oberwalder M, Fiegl H. et al .
Methylaion changes in faecal DNA: a marker for colorectal screenng?.
Lancet.
2004;
363
1283-1285
-
10
Ribic C M, Sargent D J, Moore M J. et al .
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
N Engl J Med.
2003;
349
247-257
-
11
Sidransky D, Tokino T, Hamilton S R. et al .
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
Science.
1992;
256
102-105
-
12
Traverso G, Shuber A, Levin B. et al .
Detection of APC mutations in fecal DNA from patients with colorectal tumors.
N Engl J Med.
2002;
346
311-320
-
13
Traverso G, Shuber A, Olsson L. et al .
Detection of proximal colorectal cancers through analysis of faecal DNA.
Lancet.
2002;
359
403-404
-
14
Watanabe T, Wu T T, Catalano P J. et al .
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
N Engl J Med.
2001;
344
1196-1206
-
15
Zhou W, Goodman S N, Galizia G. et al .
Counting alleles to predict recurrence of early-stage colorectal cancers.
Lancet.
2002;
359
219-225
Dr. med. Christian N. Arnold
Medizinische Universitätsklinik Freiburg, Abteilung Innere Medizin II
Hugstetter Straße 55
79106 Freiburg
Phone: 0761/2703401
Fax: 0761/2703655
Email: arnold@med1.ukl.uni-freiburg.de
